Lpl Financial LLC Verrica Pharmaceuticals Inc. Transaction History

Lpl Financial LLC

  • $196 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.93 - $7.32 $5,842 - $14,596
-1,994 Reduced 5.52%
34,136 $249,000
Q3 2023

Nov 13, 2023
BUY
$3.75 - $7.46 $3,750 - $7,460
1,000 Added 2.85%
36,130 $140,000
Q1 2023

May 10, 2023
BUY
$2.88 - $8.51 $26,294 - $77,696
9,130 Added 35.12%
35,130 $228,000
Q4 2022

Feb 07, 2023
BUY
$2.09 - $3.39 $8,360 - $13,560
4,000 Added 18.18%
26,000 $71,000
Q3 2022

Nov 14, 2022
BUY
$2.17 - $4.3 $47,740 - $94,600
22,000 New
22,000 $64,000

Others Institutions Holding VRCA

# of Institutions
71
Shares Held
17.4M
Call Options Held
6.1K
Put Options Held
6.3K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email